Immunohistochemical expression of ARID1A in penile squamous cell carcinomas: A tissue microarray study of 112 cases

Human Pathology

Volumn 46, Issue 5, 2015, Pages 761-766

  Faraj, Sheila F ^a   Chaux, Alcides ^a,b   Gonzalez Roibon, Nilda ^a   Munari, Enrico ^a   Cubilla, Antonio L ^c   Shih, Ie Ming ^a   Netto, George J ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b Gral Santos E/ 25 de Mayo   (Paraguay)

^c INSTITUTO DE PATOLOGÍA E INVESTIGACIÓN   (Paraguay)

Author keywords

ARID1A; BAF250A; mTOR pathway; Penile SCC; SWI SNF

Indexed keywords

ARID1A PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PROTEIN S6; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; VIRUS DNA; ARID1A PROTEIN, HUMAN; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; BASAL CELL CARCINOMA; CANCER GRADING; CORRELATION ANALYSIS; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PAPILLARY CARCINOMA; PAPILLOMAVIRUS INFECTION; PENILE SQUAMOUS CELL CARCINOMA; PENIS BASAL CELL CARCINOMA; PENIS CANCER; PENIS PAPILLARY CARCINOMA; PENIS SARCOMATOID CARCINOMA; PENIS VERRUCOUS CARCINOMA; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SARCOMATOID CARCINOMA; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY; VERRUCOUS CARCINOMA; WESTERN BLOTTING; CHROMATIN ASSEMBLY AND DISASSEMBLY; GENETICS; METABOLISM; PATHOLOGY; PENIS TUMOR; PROCEDURES; PROGNOSIS;

CARCINOMA, SQUAMOUS CELL; CHROMATIN ASSEMBLY AND DISASSEMBLY; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NUCLEAR PROTEINS; PENILE NEOPLASMS; PROGNOSIS; TISSUE ARRAY ANALYSIS; TRANSCRIPTION FACTORS;

EID: 84930977766     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2015.01.018     Document Type: Article

References (33)

1. A. Chaux, and A.L. Cubilla Advances in the pathology of penile carcinomas Hum Pathol 43 2012 771 789
2. A. Chaux, E.F. Velazquez, F. Algaba, G. Ayala, and A.L. Cubilla Developments in the pathology of penile squamous cell carcinomas Urology 76 2010 S7 S14
3. G. Pizzocaro, F. Algaba, S. Horenblas, and et al. European Association of Urology Guidelines Group on Penile C. EAU penile cancer guidelines 2009 Eur Urol 57 2010 1002 1012
4. C. Bermejo, J.E. Busby, P.E. Spiess, L. Heller, L.C. Pagliaro, and C.A. Pettaway Neoadjuvant chemotherapy followed by aggressive surgical consolidation for metastatic penile squamous cell carcinoma J Urol 177 2007 1335 1338
5. C. Theodore, I. Skoneczna, I. Bodrogi, and et al. A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992) Ann Oncol 19 2008 1304 1307
6. A. Chaux, and A.L. Cubilla Penile cancer: optimal management of T1G2 penile cancer remains unclear Nat Rev Urol 10 2013 9 11
7. A.M. Mosconi, F. Roila, G. Gatta, and C. Theodore Cancer of the penis Crit Rev Oncol Hematol 53 2005 165 177
8. Y. Zhu, H.L. Zhang, X.D. Yao, and et al. Development and evaluation of a nomogram to predict inguinal lymph node metastasis in patients with penile cancer and clinically negative lymph nodes J Urol 184 2010 539 545
9. A. Lopes, A.L. Bezerra, C.A. Pinto, S.V. Serrano, C.A. de MellO, and L.L. Villa p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy J Urol 168 2002 81 86
10. C. Ferrandiz-Pulido, E. Masferrer, A. Toll, and et al. mTOR signaling pathway in penile squamous cell carcinoma: pmTOR and peIF4E over expression correlate with aggressive tumor behavior J Urol 190 2013 2288 2295
11. S. Jones, M. Li, D.W. Parsons, and et al. Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types Hum Mutat 33 2012 100 103
12. J.N. Wu, and C.W. Roberts ARID1A mutations in cancer: another epigenetic tumor suppressor? Cancer Discov 3 2013 35 43
13. B. Guan, T.L. Wang, and Ie M. Shih ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers Cancer Res 71 2011 6718 6727
14. R.J. Kurman, and Ie M. Shih Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer - shifting the paradigm Hum Pathol 42 2011 918 931
15. H.L. Fedor, and A.M. De Marzo Practical methods for tissue microarray construction Methods Mol Med 103 2005 89 101
16. J.H. Epstein, A.L. Cubilla, and P.A. Humphrey Tumors of the prostate gland, seminal vesicles, penis, and scrotum 2011 American Registry of Pathology in collaboration with the Armed Forces Institute of Pathology Washington, DC 405 612
17. A. Chaux, J. Torres, R. Pfannl, and et al. Histologic grade in penile squamous cell carcinoma: visual estimation versus digital measurement of proportions of grades, adverse prognosis with any proportion of grade 3 and correlation of a Gleason-like system with nodal metastasis Am J Surg Pathol 33 2009 1042 1048
18. A.L. Cubilla, B. Lloveras, M. Alejo, and et al. The basaloid cell is the best tissue marker for human papillomavirus in invasive penile squamous cell carcinoma: a study of 202 cases from Paraguay Am J Surg Pathol 34 2010 104 114
19. B. Guan, T.L. Mao, P.K. Panuganti, and et al. Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma Am J Surg Pathol 35 2011 625 632
20. A. Chaux, E. Munari, A.L. Cubilla, and et al. Immunohistochemical expression of the mammalian target of rapamycin pathway in penile squamous cell carcinomas: a tissue microarray study of 112 cases Histopathology 64 2014 863 871
21. L. Schultz, A. Chaux, R. Albadine, and et al. Immunoexpression status and prognostic value of mTOR and hypoxia-induced pathway members in primary and metastatic clear cell renal cell carcinomas Am J Surg Pathol 35 2011 1549 1556
22. A. Katagiri, K. Nakayama, M.T. Rahman, and et al. Frequent loss of tumor suppressor ARID1A protein expression in adenocarcinomas/adenosquamous carcinomas of the uterine cervix Int J Gynecol Cancer 22 2012 208 212
23. N. Wang, Y. Zhou, L. Zheng, and H. Li MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A Gynecol Oncol 134 2014 129 137
24. H. Cho, J.S. Kim, H. Chung, C. Perry, H. Lee, and J.H. Kim Loss of ARID1A/BAF250a expression is linked to tumor progression and adverse prognosis in cervical cancer Hum Pathol 44 2013 1365 1374
25. A. Katagiri, K. Nakayama, M.T. Rahman, and et al. Loss of ARID1A expression is related to shorter progression-free survival and chemoresistance in ovarian clear cell carcinoma Mod Pathol 25 2012 282 288
26. Y. Yokoyama, Y. Matsushita, T. Shigeto, M. Futagami, and H. Mizunuma Decreased ARID1A expression is correlated with chemoresistance in epithelial ovarian cancer J Gynecol Oncol 25 2014 58 63
27. E. Stankiewicz, D.M. Prowse, M. Ng, and et al. Alternative HER/PTEN/Akt pathway activation in HPV positive and negative penile carcinomas PLoS One 6 2011 e17517
28. B. Guan, Y.S. Rahmanto, R.C. Wu, and et al. Roles of deletion of Arid1a, a tumor suppressor, in mouse ovarian tumorigenesis J Natl Cancer Inst 106 2014 dju146
29. K.C. Wiegand, B.T. Hennessy, S. Leung, and et al. A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylation BMC Cancer 14 2014 120
30. S. Yamamoto, H. Tsuda, M. Takano, S. Tamai, and O. Matsubara Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations Mod Pathol 25 2012 615 624
31. Z.J. Zang, I. Cutcutache, S.L. Poon, and et al. Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes Nat Genet 44 2012 570 574
32. E.P. Samartzis, K. Gutsche, K.J. Dedes, D. Fink, M. Stucki, and P. Imesch Loss of ARID1A expression sensitizes cancer cells to PI3K- and AKT-inhibition Oncotarget 5 2014 5295 5303
33. R.L. Camp, V. Neumeister, and D.L. Rimm A decade of tissue microarrays: progress in the discovery and validation of cancer biomarkers J Clin Oncol 26 2008 5630 5637